CSIMarket
 


Travere Therapeutics Inc   (TVTX)
Other Ticker:  
 
 

TVTX's EPS Net Growth by Quarter and Year

Travere Therapeutics Inc 's EPS Net results by quarter and year




TVTX EPS Net (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -1.07 -0.98 -0.84 -0.44
III Quarter September 1.97 -1.09 -0.59 -0.58
II Quarter June -1.13 -1.05 -0.64 0.02
I Quarter March -1.27 -1.20 -0.96 -0.70
FY   -1.50 -4.32 -3.03 -1.70



TVTX EPS Net fourth quarter 2023 Y/Y Growth Comment
Travere Therapeutics Inc in the fourth quarter 2023 recorded EPS net loss of $ -1.07 .

According to the results reported in the fourth quarter 2023, Travere Therapeutics Inc achieved the best EPS Net growth in Major Pharmaceutical Preparations industry. While Travere Therapeutics Inc ' s EPS Net no change of % ranks overall at the positon no. in the fourth quarter 2023.




TVTX EPS Net ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Travere Therapeutics Inc 's fourth quarter 2023 EPS Net $ -1.07 TVTX's Income Statement
Travere Therapeutics Inc 's fourth quarter 2022 EPS Net $ -0.98 Quarterly TVTX's Income Statement
New: More TVTX's historic EPS Net Growth >>


TVTX EPS Net (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Travere Therapeutics Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TVTX's IV. Quarter Q/Q EPS Net Comment
Recent EPS net loss of -1.07 by Travere Therapeutics Inc look even more unfavourable compare to the 1.97 EPS net loss in the previous quarter.

Within Major Pharmaceutical Preparations industry Travere Therapeutics Inc achieved highest sequential EPS Net growth. While Travere Therapeutics Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TVTX's IV. Quarter Q/Q EPS Net Comment
IV. Quarter 2023 accomplishment of -1.07 by Travere Therapeutics Inc come out even more unfavourable compare to the 1.97 EPS net loss in the third quarter.

Within Major Pharmaceutical Preparations industry Travere Therapeutics Inc achieved highest sequential EPS Net growth. While Travere Therapeutics Inc 's EPS Net growth quarter on quarter, overall rank is .


Travere Therapeutics Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative EPS Net 12 Months Ending $ -1.50 $ -1.41 $ -4.47 $ -4.39 $ -4.32
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment


Travere Therapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment


Travere Therapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
TVTX's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for TVTX's Competitors
EPS Net Growth for Travere Therapeutics Inc 's Suppliers
EPS Net Growth for TVTX's Customers

You may also want to know
TVTX's Annual Growth Rates TVTX's Profitability Ratios TVTX's Asset Turnover Ratio TVTX's Dividend Growth
TVTX's Roe TVTX's Valuation Ratios TVTX's Financial Strength Ratios TVTX's Dividend Payout Ratio
TVTX's Roa TVTX's Inventory Turnover Ratio TVTX's Growth Rates TVTX's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Dec 31 2023
Zoetis Inc 15.51%$ 15.514 
Steris Plc14.52%$ 14.516 
Medpace Holdings Inc 13.12%$ 13.116 
Eli Lilly And Company12.87%$ 12.869 
Idexx Laboratories Inc11.69%$ 11.686 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com